MarketCap
Facebook
X
TelegramHill-Rom Holdings, Inc. Retained Earnings 2011-2026 | HRC
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Hill-Rom Holdings, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 2.13 B | 1.97 B | 1.88 B | 1.68 B | 1.59 B | 1.51 B | 1.5 B | 1.47 B | 1.4 B | 1.31 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.13 B | 1.31 B | 1.64 B |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
7.64 B | $ 60.08 | -0.5 % | $ 12 B |  USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
iRhythm Technologies
IRTC
|
-803 M | $ 115.64 | 1.3 % | $ 3.7 B | USA |
 |
ICU Medical
ICUI
|
691 M | $ 120.74 | -1.83 % | $ 2.98 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
7.01 B | $ 425.83 | -0.52 % | $ 152 B | USA |
 |
Repro Med Systems
KRMD
|
-32 M | $ 3.91 | -1.76 % | $ 181 M | USA |
 |
LeMaitre Vascular
LMAT
|
185 M | $ 97.36 | -2.15 % | $ 2.2 B | USA |
 |
Alcon
ALC
|
19.4 B | $ 63.82 | -0.31 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
1.49 B | $ 178.36 | - | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-262 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
-440 M | $ 23.62 | -0.96 % | $ 3.97 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
-191 M | $ 6.08 | -5.52 % | $ 51.6 K | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 57.3 | 0.37 % | $ 2.88 B | USA |
 |
STAAR Surgical Company
STAA
|
-148 M | $ 32.72 | 2.22 % | $ 1.62 B | USA |
 |
STERIS plc
STE
|
2.48 B | $ 213.38 | -1.2 % | $ 21 B | USA |
 |
Teleflex Incorporated
TFX
|
3.15 B | $ 129.54 | -0.57 % | $ 5.78 B | USA |
 |
Isoray
ISR
|
-335 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 142.4 | 0.16 % | $ 6.9 B | USA |
 |
InfuSystem Holdings
INFU
|
-60.7 M | $ 8.73 | 1.39 % | $ 180 M | USA |
 |
Microbot Medical
MBOT
|
-104 M | $ 1.89 | 2.17 % | $ 86.5 M |  Israel |
 |
Milestone Scientific
MLSS
|
-134 M | $ 0.33 | -2.12 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
824 M | $ 61.83 | -1.17 % | $ 3.66 B | USA |
 |
Utah Medical Products
UTMD
|
129 M | $ 63.27 | -0.68 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
4.37 B | $ 303.19 | 1.0 % | $ 21.9 B | USA |
 |
Pulse Biosciences
PLSE
|
-463 M | $ 24.21 | -10.66 % | $ 1.63 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-1.56 B | $ 9.98 | -4.13 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
13.9 M | $ 0.69 | - | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 59.84 | 2.03 % | $ 197 M | USA |
 |
Predictive Oncology
POAI
|
-414 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
-340 M | $ 20.52 | -2.56 % | $ 980 M | USA |
 |
Stereotaxis
STXS
|
-583 M | $ 1.88 | -3.34 % | $ 171 M | USA |
 |
Baxter International
BAX
|
13.7 B | $ 17.32 | -2.62 % | $ 8.89 B | USA |
 |
ResMed
RMD
|
3.61 B | $ 203.11 | 0.32 % | $ 29.7 B | USA |
 |
AtriCure
ATRC
|
-413 M | $ 28.04 | -0.41 % | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
-215 M | $ 5.34 | -3.26 % | $ 237 M | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 10.92 | -1.0 % | $ 446 M | USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 142.12 | -1.63 % | $ 40.9 B | USA |
 |
Nephros
NEPH
|
-143 M | $ 3.27 | -2.1 % | $ 34.7 M | USA |
 |
OraSure Technologies
OSUR
|
-172 M | $ 3.12 | 5.59 % | $ 229 M | USA |
 |
Repligen Corporation
RGEN
|
456 M | $ 106.1 | 2.63 % | $ 5.97 M | USA |